Similar companies
Income Statement (USD)
| Q2 '25 | QoQ | |
|---|---|---|
| Revenue | 1.02B | 1.8% |
| Gross Profit | 577M | 50.9% |
| Cost of Revenue | 447M | 28.3% |
| Operating expense | 322M | 16.2% |
| Net Income | 195M | 1220.1% |
| EBITDA | 334M | 4871.4% |
Balance Sheet (USD)
| Q2 '25 | QoQ | |
|---|---|---|
| Total Assets | 8.81B | 3.1% |
| Total Liabilities | 3.96B | 0.9% |
| Total Equity | 4.84B | 4.8% |
| Shares Outstanding | 225M | 0.1% |
Cash Flow (USD)
| Q2 '25 | QoQ | |
|---|---|---|
| Cash from operations | 343M | 102.7% |
| Cash from investing | -4.3M | 98.7% |
| Cash from financing | -40M | 80.1% |
EPS
Financial Highlights for Hologic in Q2 '25
Hologic reported a revenue of 1.02B, which is a 1.8% change from the previous quarter. An increase in revenue typically indicates growing demand for the company's products or services. This positive change in revenue is a good sign, suggesting that the company's sales are moving in the right direction.
Gross Profit stood at 577M, marking a 50.9% change since the last quarter. Gross profit showcases the efficiency in production and sales processes.
Cost of Revenue was 447M, a -28.3% difference from the previous quarter. A rising cost of revenue may suggest increased production or sales costs, which can impact margins. However, if accompanied by a proportionate rise in revenue, it could indicate scaling operations.
Operating Expenses for this period were 322M, showing a -16.2% change from the last quarter. Operating expenses cover the costs of running daily business operations. A significant increase might indicate inefficiencies or investments in growth, while a decrease could suggest cost-saving measures or potential underinvestment in key areas.
Net Income for the quarter was 195M, showing a 1220.1% change from the prior quarter. Net income provides a clear picture of the company's profitability after all expenses. An increase suggests the company is becoming more profitable, while a decrease may raise concerns about the company's financial health, unless there are specific one-time costs or investments.
The company's EBITDA for the quarter was 334M, showing a 4871.4% change from the previous period. EBITDA gives insight into the company's operational profitability, excluding non-operating expenses like interest and taxes. A rising EBITDA indicates strong operational performance, while a declining EBITDA may signal operational challenges or increased costs.
It was a positive quarter for Hologic with growth in revenue, gross profit, and net income.
